Back to BlackRock, Inc. BlackRock, Inc.

FBRXFBRX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in Forte Biosciences Inc.

BlackRock, Inc. holds 1.2M shares of FBRX (Forte Biosciences Inc.), worth $26M as of 2026-Q2. The position was increased (+1755.0% shares). FBRX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$26M

Current Shares

1.2M

Total Value Change

+$25.8M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+1755.0%
$26M0.0%$21.25
46
2026-Q1
Increased
65,921
+2.2%
$1.7M0.0%$30.42
18
2025-Q4
Increased
64,496
+27.3%
$1.8M0.0%$26.27
22
2025-Q3
Increased
50,662
+50.4%
$759,9300.0%$14.48
23
2025-Q2
Increased
33,695
+395.3%
$435,6760.0%$12.25
26
2025-Q1
Unchanged
6,803
0.0%
$52,7910.0%$8.20
0
2024-Q4
New
6,803
-
$154,4960.0%$21.14
34

Other major holders of FBRX: FEDERATED HERMES, INC., FRED ALGER MANAGEMENT, LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used